Our observation that induced CDX2 expression in LS174T cells promotes an increased ST14/SPINT1 ratio does not correlate with the reported expression pattern of decreased CDX2 levels and increased ST14/SPINT1 levels during colon cancer progression. The gene discussed is CDX2; the disease is colonic neoplasm.